Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Adam Eckert

EXCLUSIVE: Tonix Pharmaceuticals CEO Highlights Advantages Of Company's Monkeypox Vaccine In Development

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are soaring Monday after the World Health Organization (WHO) declared monkeypox a public health emergency of global concern. Tonix's TNX-801 is being developed as a vaccine to protect against monkeypox. 

"We already have very compelling data showing protection of monkeys against the lethal challenge of monkeypox," Tonix CEO Seth Lederman said Monday on Benzinga's YouTube show "Stock Market Movers."

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.